Dibasic Sodium Phosphate, Monobasic Potassium Phosphate And Monobasic Sodium Phosphate
NDC Package 68151-2195-0

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Dibasic Sodium Phosphate, Monobasic Potassium Phosphate And Monobasic Sodium Phosphate is pHOSPHA 250 NEUTRAL increases urinary phosphate and pyrophosphate. Marketed by Carilion Materials Management, this product is identified by NDC 68151-2195.

Identification & Billing

NDC Package Code
68151-2195-0
Package Description
1 TABLET in 1 PACKAGE
Product Code
68151-2195
11-Digit Billing Format
68151219500
RxNorm Crosswalk
  • RxCUI: 200251 - sodium phosphate, dibasic 852 MG / potassium phosphate, monobasic 155 MG / sodium phosphate, monobasic 130 MG Oral Tablet
  • RxCUI: 200251 - potassium phosphate 155 MG / sodium phosphate, dibasic 852 MG / sodium phosphate, monobasic 130 MG Oral Tablet
  • RxCUI: 200251 - K+ phosphate 155 MG / Sodium Phosphate, Dibasic 852 MG / Sodium Phosphate, Monobasic 130 MG Oral Tablet
  • RxCUI: 200251 - Pot phosphate 155 MG / Sodium Phosphate, Dibasic 852 MG / Sodium Phosphate, Monobasic 130 MG Oral Tablet

Clinical Specifications

Proprietary Name
Dibasic Sodium Phosphate, Monobasic Potassium Phosphate And Monobasic Sodium Phosphate
Dosage Form
-
Usage Information
PHOSPHA 250 NEUTRAL increases urinary phosphate and pyrophosphate. As a phosphorus supplement, each tablet supplies 25% of the U.S. Recommended Daily Allowance (U.S. RDA) of phosphorus for adults and children over 4 years of age. TM

Regulatory & Marketing

Labeler Name
Carilion Materials Management
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
06-28-2012
Listing Expiration
12-31-2018
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 68151-2195-0 identifies a specific commercial package of 1 tablet in 1 package of Dibasic Sodium Phosphate, Monobasic Potassium Phosphate And Monobasic Sodium Phosphate, labeled by Carilion Materials Management. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Carilion Materials Management on June 28, 2012. The current certification is valid through December 31, 2018.

How is this Carilion Materials Management product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 68151219500. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
68151-2195-0
11-Digit CMS (5-4-2)
68151-2195-00

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.